Lung Cancer Clinical Trial
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Summary
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Full Description
PRIMARY OBJECTIVES:
I. Conduct a randomized, controlled trial evaluating the efficacy of a conversation tool on patient-centered health and decision-making outcomes among patients making lung cancer treatment decisions. A subset of participants from control and intervention groups will also have their clinic conversations with providers recorded II. Conduct in-depth, semi-structured qualitative audio or video recorded interviews among a subset of Aim 1 participants.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients review decision aid.
GROUP II: Patients receive standard of care.
After completion of study intervention, patients are followed up at 2 weeks, 3 months, and 6 months.
Eligibility Criteria
Inclusion Criteria:
AIM 1: Suspected lung cancer
AIM 1: English fluency
AIM 1: > 6-month life expectancy
AIM 1: Score of ≥ 3 on the cognitive impairment screener
AIM 2 PARTICIPANTS: Participation in Aim 1
AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants
VA-SPECIFIC REQUIREMENT (inclusion of non-Veterans): Non-Veterans will be recruited for this study. Non-Veterans are an important component to this project since they will provide outside perspective. In this way, results of this study will be more generalizable
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Hillsboro Oregon, 97123, United States More Info
Principal Investigator
Portland Oregon, 97216, United States More Info
Principal Investigator
Portland Oregon, 97239, United States More Info
Principal Investigator
Portland Oregon, 97239, United States More Info
Principal Investigator
How clear is this clinincal trial information?